Seres Therapeutics, Inc. (MCRB)
NASDAQ: MCRB · Real-Time Price · USD
0.3700
-0.0299 (-7.48%)
Apr 17, 2025, 4:00 PM EDT - Market closed
Seres Therapeutics Employees
Seres Therapeutics had 103 employees as of December 31, 2024. The number of employees decreased by 130 or -55.79% compared to the previous year.
Employees
103
Change (1Y)
-130
Growth (1Y)
-55.79%
Revenue / Employee
n/a
Profits / Employee
$1,320
Market Cap
64.51M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
MCRB News
- 5 weeks ago - Seres Therapeutics, Inc. (MCRB) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 5 weeks ago - Seres Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business Updates - GlobeNewsWire
- 6 weeks ago - Seres Therapeutics to Announce Fourth Quarter and Full Year 2024 Financial Results and Provide Business Updates on March 13, 2025 - GlobeNewsWire
- 6 weeks ago - Seres Therapeutics Receives Feedback From FDA on SER-155 Allogeneic Hematopoietic Stem Cell Transplant (allo-HSCT) Development Approach - GlobeNewsWire
- 3 months ago - Seres Therapeutics Announces Receipt of Expected $50 Million Installment Payment Related to VOWST Sale - GlobeNewsWire
- 3 months ago - Seres Therapeutics Announces New Translational Biomarker Results from SER-155 Phase 1b Clinical Study and Provides Corporate Updates - GlobeNewsWire
- 4 months ago - Seres Therapeutics to Participate in 2025 J.P. Morgan Healthcare Conference - GlobeNewsWire
- 5 months ago - Seres Therapeutics to Participate in Piper Sandler Healthcare Conference - GlobeNewsWire